25 XP   0   0   10

Relief Therapeutics Holding AG
Buy, Hold or Sell?

Let's analyse Relief Therapeutics Holding AG together

PenkeI guess you are interested in Relief Therapeutics Holding AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Relief Therapeutics Holding AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Relief Therapeutics Holding AG

I send you an email if I find something interesting about Relief Therapeutics Holding AG.

Quick analysis of Relief Therapeutics Holding AG (30 sec.)










What can you expect buying and holding a share of Relief Therapeutics Holding AG? (30 sec.)

How much money do you get?

How much money do you get?
CHF2.44
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
CHF11.90
Expected worth in 1 year
CHF0.08
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
CHF-9.59
Return On Investment
-746.6%

For what price can you sell your share?

Current Price per Share
CHF1.29
Expected price per share
CHF0 - CHF1.56
How sure are you?
50%

1. Valuation of Relief Therapeutics Holding AG (5 min.)




Live pricePrice per Share (EOD)

CHF1.29

Intrinsic Value Per Share

CHF-42.61 - CHF-15.31

Total Value Per Share

CHF-30.71 - CHF-3.41

2. Growth of Relief Therapeutics Holding AG (5 min.)




Is Relief Therapeutics Holding AG growing?

Current yearPrevious yearGrowGrow %
How rich?$159.4m$199m-$39.6m-24.8%

How much money is Relief Therapeutics Holding AG making?

Current yearPrevious yearGrowGrow %
Making money-$55.6m-$38m-$17.6m-31.7%
Net Profit Margin-835.2%-1,045.0%--

How much money comes from the company's main activities?

3. Financial Health of Relief Therapeutics Holding AG (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#288 / 1010

Most Revenue
#328 / 1010

Most Profit
#901 / 1010

Most Efficient
#784 / 1010

What can you expect buying and holding a share of Relief Therapeutics Holding AG? (5 min.)

Welcome investor! Relief Therapeutics Holding AG's management wants to use your money to grow the business. In return you get a share of Relief Therapeutics Holding AG.

What can you expect buying and holding a share of Relief Therapeutics Holding AG?

First you should know what it really means to hold a share of Relief Therapeutics Holding AG. And how you can make/lose money.

Speculation

The Price per Share of Relief Therapeutics Holding AG is CHF1.285. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Relief Therapeutics Holding AG.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Relief Therapeutics Holding AG, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is CHF11.90. Based on the TTM, the Book Value Change Per Share is CHF-2.96 per quarter. Based on the YOY, the Book Value Change Per Share is CHF9.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is CHF0.56 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Relief Therapeutics Holding AG.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 CHF% of Price per ShareCHF% of Price per ShareCHF% of Price per ShareCHF% of Price per ShareCHF% of Price per Share
Usd Eps-4.56-354.7%-4.56-354.7%-3.11-242.4%-1.81-140.8%-0.92-71.3%
Usd Book Value Change Per Share-3.24-252.2%-3.24-252.2%10.28799.6%2.61203.0%1.31101.9%
Usd Dividend Per Share0.6147.5%0.6147.5%6.08472.8%2.38185.4%1.1992.7%
Usd Total Gains Per Share-2.63-204.7%-2.63-204.7%16.351,272.4%4.99388.3%2.50194.6%
Usd Price Per Share0.03-0.03-0.07-0.08-0.07-
Price to Earnings Ratio-0.01--0.01--0.02--4.98--44.04-
Price-to-Total Gains Ratio-0.01--0.01-0.00--6.73--4.05-
Price to Book Ratio0.00-0.00-0.00-0.11-0.72-
Price-to-Total Gains Ratio-0.01--0.01-0.00--6.73--4.05-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.409131
Number of shares709
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.612.38
Usd Book Value Change Per Share-3.242.61
Usd Total Gains Per Share-2.634.99
Gains per Quarter (709 shares)-1,864.823,537.78
Gains per Year (709 shares)-7,459.2814,151.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11733-9192-74696755739614141
23465-18384-14928135101479228292
35198-27576-22387202652218842443
46930-36767-29846270202958456594
58663-45959-37305337753698070745
610396-55151-44764405304437684896
712128-64343-52223472855177299047
813861-73535-596825404059169113198
915593-82727-671416079566565127349
1017326-91919-746006755073961141500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.016.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%4.06.00.040.0%5.011.00.031.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%3.00.02.060.0%3.00.07.030.0%3.00.013.018.8%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%4.06.00.040.0%5.011.00.031.3%

Fundamentals of Relief Therapeutics Holding AG

About Relief Therapeutics Holding AG

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting. It develops RLF-100, a synthetic form of vasoactive intestinal peptide (VIP) for the treatment of acute respiratory distress syndrome (ARDS) associated with COVID-19, nonCOVID-19-related ARDS, pulmonary sarcoidosis, checkpoint inhibitor-induced pneumonitis, and chronic berylliosis. The company also develops RLF-TD011, a hypochlorous acid topical sprayable solution to treat wound colonization, reduce local inflammation, alleviate symptoms, and hasten wound healing in epidermolysis bullosa. In addition, it develops OLPRUVA, a sodium phenylbutyrate for the treatment of various inborn errors of metabolism, urea cycle disorders, and maple syrup urine disease; APR-OD32, which is in phase 1 for the treatment of patients with phenylketonuria. Relief Therapeutics Holding AG was founded in 2013 and is based in Geneva, Switzerland.

Fundamental data was last updated by Penke on 2024-04-09 03:17:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Relief Therapeutics Holding AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Relief Therapeutics Holding AG earns for each CHF1 of revenue.

  • Above 10% is considered healthy but always compare Relief Therapeutics Holding AG to the Biotechnology industry mean.
  • A Net Profit Margin of -835.2% means that CHF-8.35 for each CHF1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Relief Therapeutics Holding AG:

  • The MRQ is -835.2%. The company is making a huge loss. -2
  • The TTM is -835.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-835.2%TTM-835.2%0.0%
TTM-835.2%YOY-1,045.0%+209.8%
TTM-835.2%5Y-391.5%-443.7%
5Y-391.5%10Y-11,788.0%+11,396.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-835.2%-200.1%-635.1%
TTM-835.2%-216.8%-618.4%
YOY-1,045.0%-288.3%-756.7%
5Y-391.5%-449.1%+57.6%
10Y-11,788.0%-605.5%-11,182.5%
1.1.2. Return on Assets

Shows how efficient Relief Therapeutics Holding AG is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Relief Therapeutics Holding AG to the Biotechnology industry mean.
  • -26.9% Return on Assets means that Relief Therapeutics Holding AG generated CHF-0.27 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Relief Therapeutics Holding AG:

  • The MRQ is -26.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -26.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.9%TTM-26.9%0.0%
TTM-26.9%YOY-13.8%-13.1%
TTM-26.9%5Y-17.9%-9.0%
5Y-17.9%10Y-23.9%+6.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.9%-13.3%-13.6%
TTM-26.9%-12.8%-14.1%
YOY-13.8%-11.7%-2.1%
5Y-17.9%-13.9%-4.0%
10Y-23.9%-15.7%-8.2%
1.1.3. Return on Equity

Shows how efficient Relief Therapeutics Holding AG is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Relief Therapeutics Holding AG to the Biotechnology industry mean.
  • -34.9% Return on Equity means Relief Therapeutics Holding AG generated CHF-0.35 for each CHF1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Relief Therapeutics Holding AG:

  • The MRQ is -34.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -34.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-34.9%TTM-34.9%0.0%
TTM-34.9%YOY-19.1%-15.8%
TTM-34.9%5Y-24.0%-10.9%
5Y-24.0%10Y-36.8%+12.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-34.9%-16.9%-18.0%
TTM-34.9%-16.1%-18.8%
YOY-19.1%-15.1%-4.0%
5Y-24.0%-19.3%-4.7%
10Y-36.8%-20.2%-16.6%

1.2. Operating Efficiency of Relief Therapeutics Holding AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Relief Therapeutics Holding AG is operating .

  • Measures how much profit Relief Therapeutics Holding AG makes for each CHF1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Relief Therapeutics Holding AG to the Biotechnology industry mean.
  • An Operating Margin of -601.0% means the company generated CHF-6.01  for each CHF1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Relief Therapeutics Holding AG:

  • The MRQ is -601.0%. The company is operating very inefficient. -2
  • The TTM is -601.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-601.0%TTM-601.0%0.0%
TTM-601.0%YOY-1,060.2%+459.2%
TTM-601.0%5Y-350.0%-251.0%
5Y-350.0%10Y-11,750.8%+11,400.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-601.0%-296.2%-304.8%
TTM-601.0%-232.5%-368.5%
YOY-1,060.2%-298.2%-762.0%
5Y-350.0%-492.1%+142.1%
10Y-11,750.8%-632.4%-11,118.4%
1.2.2. Operating Ratio

Measures how efficient Relief Therapeutics Holding AG is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 7.01 means that the operating costs are CHF7.01 for each CHF1 in net sales.

Let's take a look of the Operating Ratio trends of Relief Therapeutics Holding AG:

  • The MRQ is 7.010. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.010. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ7.010TTM7.0100.000
TTM7.010YOY11.602-4.592
TTM7.0105Y4.100+2.910
5Y4.10010Y16.945-12.845
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0103.231+3.779
TTM7.0103.310+3.700
YOY11.6023.890+7.712
5Y4.1005.739-1.639
10Y16.9457.876+9.069

1.3. Liquidity of Relief Therapeutics Holding AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Relief Therapeutics Holding AG is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.11 means the company has CHF2.11 in assets for each CHF1 in short-term debts.

Let's take a look of the Current Ratio trends of Relief Therapeutics Holding AG:

  • The MRQ is 2.107. The company is able to pay all its short-term debts. +1
  • The TTM is 2.107. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.107TTM2.1070.000
TTM2.107YOY2.786-0.678
TTM2.1075Y2.433-0.326
5Y2.43310Y1.493+0.940
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1073.890-1.783
TTM2.1074.173-2.066
YOY2.7865.344-2.558
5Y2.4336.126-3.693
10Y1.4936.448-4.955
1.3.2. Quick Ratio

Measures if Relief Therapeutics Holding AG is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Relief Therapeutics Holding AG to the Biotechnology industry mean.
  • A Quick Ratio of 2.01 means the company can pay off CHF2.01 for each CHF1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Relief Therapeutics Holding AG:

  • The MRQ is 2.006. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.006. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.006TTM2.0060.000
TTM2.006YOY2.407-0.402
TTM2.0065Y2.224-0.218
5Y2.22410Y1.200+1.023
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0063.514-1.508
TTM2.0063.998-1.992
YOY2.4075.380-2.973
5Y2.2246.105-3.881
10Y1.2006.404-5.204

1.4. Solvency of Relief Therapeutics Holding AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Relief Therapeutics Holding AG assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Relief Therapeutics Holding AG to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23 means that Relief Therapeutics Holding AG assets are financed with 23.0% credit (debt) and the remaining percentage (100% - 23.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Relief Therapeutics Holding AG:

  • The MRQ is 0.230. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.230. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.230TTM0.2300.000
TTM0.230YOY0.279-0.049
TTM0.2305Y0.266-0.036
5Y0.26610Y0.328-0.062
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2300.339-0.109
TTM0.2300.336-0.106
YOY0.2790.271+0.008
5Y0.2660.366-0.100
10Y0.3280.389-0.061
1.4.2. Debt to Equity Ratio

Measures if Relief Therapeutics Holding AG is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Relief Therapeutics Holding AG to the Biotechnology industry mean.
  • A Debt to Equity ratio of 29.8% means that company has CHF0.30 debt for each CHF1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Relief Therapeutics Holding AG:

  • The MRQ is 0.298. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.298. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.298TTM0.2980.000
TTM0.298YOY0.386-0.088
TTM0.2985Y0.382-0.084
5Y0.38210Y0.535-0.153
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2980.388-0.090
TTM0.2980.402-0.104
YOY0.3860.335+0.051
5Y0.3820.426-0.044
10Y0.5350.461+0.074

2. Market Valuation of Relief Therapeutics Holding AG

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every CHF1 in earnings Relief Therapeutics Holding AG generates.

  • Above 15 is considered overpriced but always compare Relief Therapeutics Holding AG to the Biotechnology industry mean.
  • A PE ratio of -0.01 means the investor is paying CHF-0.01 for every CHF1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Relief Therapeutics Holding AG:

  • The EOD is -0.309. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.007. Based on the earnings, the company is expensive. -2
  • The TTM is -0.007. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.309MRQ-0.007-0.302
MRQ-0.007TTM-0.0070.000
TTM-0.007YOY-0.022+0.015
TTM-0.0075Y-4.980+4.973
5Y-4.98010Y-44.039+39.059
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.309-2.264+1.955
MRQ-0.007-2.629+2.622
TTM-0.007-2.680+2.673
YOY-0.022-4.145+4.123
5Y-4.980-6.257+1.277
10Y-44.039-6.254-37.785
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Relief Therapeutics Holding AG:

  • The EOD is -0.637. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.015. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.015. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.637MRQ-0.015-0.623
MRQ-0.015TTM-0.0150.000
TTM-0.015YOY-0.015+0.000
TTM-0.0155Y-3.495+3.481
5Y-3.49510Y-5.732+2.237
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.637-2.973+2.336
MRQ-0.015-3.333+3.318
TTM-0.015-3.553+3.538
YOY-0.015-5.605+5.590
5Y-3.495-8.376+4.881
10Y-5.732-8.865+3.133
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Relief Therapeutics Holding AG is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.00 means the investor is paying CHF0.00 for each CHF1 in book value.

Let's take a look of the Price to Book Ratio trends of Relief Therapeutics Holding AG:

  • The EOD is 0.108. Based on the equity, the company is cheap. +2
  • The MRQ is 0.003. Based on the equity, the company is cheap. +2
  • The TTM is 0.003. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.108MRQ0.003+0.105
MRQ0.003TTM0.0030.000
TTM0.003YOY0.004-0.002
TTM0.0035Y0.111-0.109
5Y0.11110Y0.715-0.604
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.1081.896-1.788
MRQ0.0032.115-2.112
TTM0.0032.093-2.090
YOY0.0042.884-2.880
5Y0.1113.542-3.431
10Y0.7153.916-3.201
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Relief Therapeutics Holding AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---2.956-2.9560%9.370-132%2.378-224%1.194-348%
Book Value Per Share--11.90111.9010%14.857-20%6.685+78%3.366+254%
Current Ratio--2.1072.1070%2.786-24%2.433-13%1.493+41%
Debt To Asset Ratio--0.2300.2300%0.279-18%0.266-14%0.328-30%
Debt To Equity Ratio--0.2980.2980%0.386-23%0.382-22%0.535-44%
Dividend Per Share--0.5570.5570%5.540-90%2.172-74%1.086-49%
Eps---4.157-4.1570%-2.840-32%-1.650-60%-0.836-80%
Free Cash Flow Per Share---2.016-2.0160%-4.045+101%-1.523-24%-0.770-62%
Free Cash Flow To Equity Per Share---1.491-1.4910%1.495-200%0.653-328%0.326-557%
Gross Profit Margin--1.0651.0650%1.011+5%1.092-2%1.046+2%
Intrinsic Value_10Y_max---15.309--------
Intrinsic Value_10Y_min---42.611--------
Intrinsic Value_1Y_max---0.937--------
Intrinsic Value_1Y_min---2.990--------
Intrinsic Value_3Y_max---3.271--------
Intrinsic Value_3Y_min---10.145--------
Intrinsic Value_5Y_max---6.153--------
Intrinsic Value_5Y_min---18.519--------
Market Cap15700644.000+98%366552.000366552.0000%759984.480-52%3017247.805-88%15591933.097-98%
Net Profit Margin---8.352-8.3520%-10.450+25%-3.915-53%-117.880+1311%
Operating Margin---6.010-6.0100%-10.602+76%-3.500-42%-117.508+1855%
Operating Ratio--7.0107.0100%11.602-40%4.100+71%16.945-59%
Pb Ratio0.108+98%0.0030.0030%0.004-40%0.111-98%0.715-100%
Pe Ratio-0.309-4183%-0.007-0.0070%-0.022+203%-4.980+68909%-44.039+610115%
Price Per Share1.285+98%0.0300.0300%0.062-52%0.073-59%0.063-52%
Price To Free Cash Flow Ratio-0.637-4183%-0.015-0.0150%-0.015+3%-3.495+23386%-5.732+38415%
Price To Total Gains Ratio-0.536-4183%-0.013-0.0130%0.004-400%-6.734+53735%-4.045+32242%
Quick Ratio--2.0062.0060%2.407-17%2.224-10%1.200+67%
Return On Assets---0.269-0.2690%-0.138-49%-0.179-33%-0.239-11%
Return On Equity---0.349-0.3490%-0.191-45%-0.240-31%-0.368+5%
Total Gains Per Share---2.399-2.3990%14.910-116%4.550-153%2.280-205%
Usd Book Value--159464282.200159464282.2000%199065798.000-20%94213511.720+69%58928175.076+171%
Usd Book Value Change Per Share---3.241-3.2410%10.275-132%2.608-224%1.309-348%
Usd Book Value Per Share--13.05113.0510%16.292-20%7.331+78%3.691+254%
Usd Dividend Per Share--0.6110.6110%6.075-90%2.382-74%1.191-49%
Usd Eps---4.558-4.5580%-3.115-32%-1.809-60%-0.917-80%
Usd Free Cash Flow---27008161.400-27008161.4000%-54192875.400+101%-20538879.360-24%-13612109.077-50%
Usd Free Cash Flow Per Share---2.210-2.2100%-4.435+101%-1.670-24%-0.845-62%
Usd Free Cash Flow To Equity Per Share---1.635-1.6350%1.640-200%0.716-328%0.358-557%
Usd Market Cap17217326.210+98%401960.923401960.9230%833398.981-52%3308713.943-88%17098113.834-98%
Usd Price Per Share1.409+98%0.0330.0330%0.068-52%0.081-59%0.069-52%
Usd Profit---55696314.000-55696314.0000%-38057503.000-32%-22199351.080-60%-16947537.417-70%
Usd Revenue--6668424.6006668424.6000%3641808.600+83%2185962.440+205%5531538.942+21%
Usd Total Gains Per Share---2.630-2.6300%16.350-116%4.990-153%2.500-205%
 EOD+5 -3MRQTTM+0 -0YOY+12 -245Y+9 -2710Y+16 -20

3.2. Fundamental Score

Let's check the fundamental score of Relief Therapeutics Holding AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.309
Price to Book Ratio (EOD)Between0-10.108
Net Profit Margin (MRQ)Greater than0-8.352
Operating Margin (MRQ)Greater than0-6.010
Quick Ratio (MRQ)Greater than12.006
Current Ratio (MRQ)Greater than12.107
Debt to Asset Ratio (MRQ)Less than10.230
Debt to Equity Ratio (MRQ)Less than10.298
Return on Equity (MRQ)Greater than0.15-0.349
Return on Assets (MRQ)Greater than0.05-0.269
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Relief Therapeutics Holding AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.022
Ma 20Greater thanMa 501.298
Ma 50Greater thanMa 1001.425
Ma 100Greater thanMa 2001.587
OpenGreater thanClose1.250
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CHF. All numbers in thousands.

Summary
Total Assets188,798
Total Liabilities43,381
Total Stockholder Equity145,417
 As reported
Total Liabilities 43,381
Total Stockholder Equity+ 145,417
Total Assets = 188,798

Assets

Total Assets188,798
Total Current Assets22,583
Long-term Assets166,215
Total Current Assets
Cash And Cash Equivalents 19,237
Net Receivables 2,255
Inventory 227
Other Current Assets 864
Total Current Assets  (as reported)22,583
Total Current Assets  (calculated)22,583
+/-0
Long-term Assets
Property Plant Equipment 2,691
Goodwill 7,018
Intangible Assets 162,915
Long-term Assets  (as reported)166,215
Long-term Assets  (calculated)172,624
+/- 6,409

Liabilities & Shareholders' Equity

Total Current Liabilities10,716
Long-term Liabilities32,665
Total Stockholder Equity145,417
Total Current Liabilities
Short-term Debt 2,096
Short Long Term Debt 372
Accounts payable 1,625
Other Current Liabilities 6,219
Total Current Liabilities  (as reported)10,716
Total Current Liabilities  (calculated)10,312
+/- 404
Long-term Liabilities
Long term Debt 16
Capital Lease Obligations 2,676
Long-term Liabilities  (as reported)32,665
Long-term Liabilities  (calculated)2,692
+/- 29,973
Total Stockholder Equity
Common Stock56,163
Retained Earnings -119,599
Accumulated Other Comprehensive Income 5,273
Other Stockholders Equity 203,580
Total Stockholder Equity (as reported)145,417
Total Stockholder Equity (calculated)145,417
+/-0
Other
Capital Stock56,163
Cash and Short Term Investments 19,237
Common Stock Shares Outstanding 10,570
Current Deferred Revenue776
Liabilities and Stockholders Equity 188,798
Net Debt -14,893
Net Invested Capital 145,805
Net Working Capital 11,867
Property Plant and Equipment Gross 3,264
Short Long Term Debt Total 4,344



Balance Sheet

Currency in CHF. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
79,130
76,662
65,218
58,303
3,277
1,287
45,980
41,621
30,133
31,423
30,971
35,576
19,863
78,045
251,618
188,798
188,798251,61878,04519,86335,57630,97131,42330,13341,62145,9801,2873,27758,30365,21876,66279,130
   > Total Current Assets 
17,415
21,573
8,901
9,381
2,375
703
12,230
10,474
7,635
615
166
351
263
46,853
54,970
22,583
22,58354,97046,8532633511666157,63510,47412,2307032,3759,3818,90121,57317,415
       Cash And Cash Equivalents 
11,009
14,085
4,632
2,396
1,805
334
947
5,006
333
394
135
265
129
43,154
44,761
19,237
19,23744,76143,1541292651353943335,0069473341,8052,3964,63214,08511,009
       Short-term Investments 
0
0
0
0
0
0
26
0
0
0
0
0
0
185
0
0
0018500000026000000
       Net Receivables 
0
0
1,000
0
0
0
0
0
0
106
24
17
87
72
2,746
2,255
2,2552,746728717241060000001,00000
       Other Current Assets 
6,406
7,488
4,270
6,985
571
369
11,212
5,428
7,302
221
31
86
47
3,627
7,072
864
8647,0723,6274786312217,3025,42811,2123695716,9854,2707,4886,406
   > Long-term Assets 
61,715
55,088
56,317
48,922
902
584
33,750
31,147
22,498
30,808
30,805
35,225
19,600
31,192
196,648
166,215
166,215196,64831,19219,60035,22530,80530,80822,49831,14733,75058490248,92256,31755,08861,715
       Property Plant Equipment 
5,158
1,553
5,796
1,415
902
584
842
2,852
12
8
5
1
7
0
2,536
2,691
2,6912,53607158122,8528425849021,4155,7961,5535,158
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,658
7,018
7,0188,65800000000000000
       Intangible Assets 
56,557
53,535
50,521
0
0
0
0
0
0
30,800
30,800
35,224
19,600
30,800
192,299
162,915
162,915192,29930,80019,60035,22430,80030,80000000050,52153,53556,557
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
392
1,813
0
01,8133920000000000000
> Total Liabilities 
14,634
7,725
8,485
5,927
2,813
3,974
25,366
15,272
12,476
9,187
10,026
14,293
5,565
11,002
70,088
43,381
43,38170,08811,0025,56514,29310,0269,18712,47615,27225,3663,9742,8135,9278,4857,72514,634
   > Total Current Liabilities 
11,098
7,395
8,317
5,294
2,495
3,659
19,910
12,003
9,259
1,647
2,035
1,960
2,823
6,693
19,733
10,716
10,71619,7336,6932,8231,9602,0351,6479,25912,00319,9103,6592,4955,2948,3177,39511,098
       Short-term Debt 
243
187
164
124
550
2,645
5,223
3,689
2,535
0
1,012
328
1,739
0
1,676
2,096
2,0961,67601,7393281,01202,5353,6895,2232,645550124164187243
       Short Long Term Debt 
0
0
0
0
1,000
3,000
0
0
0
0
1,012
328
962
0
95
372
3729509623281,01200003,0001,0000000
       Accounts payable 
7,714
781
2,000
2,000
1,000
1,000
7,577
4,698
413
383
493
119
283
1,432
1,700
1,625
1,6251,7001,4322831194933834134,6987,5771,0001,0002,0002,0007817,714
       Other Current Liabilities 
3,142
6,427
8,153
5,170
1,946
1,015
7,110
3,616
6,311
1,264
530
1,513
763
5,261
15,871
6,219
6,21915,8715,2617631,5135301,2646,3113,6167,1101,0151,9465,1708,1536,4273,142
   > Long-term Liabilities 
3,536
331
169
633
318
314
5,456
3,269
3,217
7,540
7,991
12,333
2,742
4,309
50,355
32,665
32,66550,3554,3092,74212,3337,9917,5403,2173,2695,4563143186331693313,536
       Other Liabilities 
0
0
0
0
0
0
0
0
0
7,540
7,991
12,333
2,742
4,309
47,767
0
047,7674,3092,74212,3337,9917,540000000000
> Total Stockholder Equity
64,496
68,936
56,733
52,376
464
-2,686
20,154
26,361
17,657
22,236
20,945
21,283
14,298
67,043
181,530
145,417
145,417181,53067,04314,29821,28320,94522,23617,65726,36120,154-2,68646452,37656,73368,93664,496
   Common Stock
643
654
654
673
689
697
3,973
6,546
5,884
19,466
20,066
20,889
21,139
32,467
44,133
56,163
56,16344,13332,46721,13920,88920,06619,4665,8846,5463,973697689673654654643
   Retained Earnings -119,599-69,751-35,198-27,506-20,516-20,082-17,827-20,043-13,288-1,254-117,131-113,984-54,818-35,421-23,208-13,807
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
77,660
91,490
93,906
107,652
115,139
114,620
21,055
37,839
32,475
20,607
20,974
20,927
20,451
68,546
204,522
203,580
203,580204,52268,54620,45120,92720,97420,60732,47537,83921,055114,620115,139107,65293,90691,49077,660



Balance Sheet

Currency in CHF. All numbers in thousands.




Cash Flow

Currency in CHF. All numbers in thousands.




Income Statement

Currency in CHF. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue6,081
Cost of Revenue-18,108
Gross Profit-12,027-12,027
 
Operating Income (+$)
Gross Profit-12,027
Operating Expense-24,520
Operating Income-36,547-36,547
 
Operating Expense (+$)
Research Development12,393
Selling General Administrative7,747
Selling And Marketing Expenses3,307
Operating Expense24,52023,447
 
Net Interest Income (+$)
Interest Income18
Interest Expense-196
Other Finance Cost-416
Net Interest Income-594
 
Pretax Income (+$)
Operating Income-36,547
Net Interest Income-594
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-54,316-18,778
EBIT - interestExpense = -36,743
-54,316
-50,594
Interest Expense196
Earnings Before Interest and Taxes (EBIT)-36,547-54,120
Earnings Before Interest and Taxes (EBITDA)-32,687
 
After tax Income (+$)
Income Before Tax-54,316
Tax Provision--3,526
Net Income From Continuing Ops-50,790-50,790
Net Income-50,790
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses42,628
Total Other Income/Expenses Net-17,769594
 

Technical Analysis of Relief Therapeutics Holding AG
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Relief Therapeutics Holding AG. The general trend of Relief Therapeutics Holding AG is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Relief Therapeutics Holding AG's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Relief Therapeutics Holding AG.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.47 < 1.5 < 1.56.

The bearish price targets are: .

Tweet this
Relief Therapeutics Holding AG Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Relief Therapeutics Holding AG. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Relief Therapeutics Holding AG Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Relief Therapeutics Holding AG. The current macd is -0.04266233.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Relief Therapeutics Holding AG price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Relief Therapeutics Holding AG. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Relief Therapeutics Holding AG price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Relief Therapeutics Holding AG Daily Moving Average Convergence/Divergence (MACD) ChartRelief Therapeutics Holding AG Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Relief Therapeutics Holding AG. The current adx is 26.11.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Relief Therapeutics Holding AG shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Relief Therapeutics Holding AG Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Relief Therapeutics Holding AG. The current sar is 1.2.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Relief Therapeutics Holding AG Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Relief Therapeutics Holding AG. The current rsi is 45.02. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Relief Therapeutics Holding AG Daily Relative Strength Index (RSI) ChartRelief Therapeutics Holding AG Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Relief Therapeutics Holding AG. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 3/(-6 +6).

  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Relief Therapeutics Holding AG price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Relief Therapeutics Holding AG Daily Stochastic Oscillator ChartRelief Therapeutics Holding AG Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Relief Therapeutics Holding AG. The current cci is -63.02944138.

Relief Therapeutics Holding AG Daily Commodity Channel Index (CCI) ChartRelief Therapeutics Holding AG Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Relief Therapeutics Holding AG. The current cmo is -3.78256564.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Relief Therapeutics Holding AG Daily Chande Momentum Oscillator (CMO) ChartRelief Therapeutics Holding AG Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Relief Therapeutics Holding AG. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Relief Therapeutics Holding AG is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Relief Therapeutics Holding AG Daily Williams %R ChartRelief Therapeutics Holding AG Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Relief Therapeutics Holding AG.

Relief Therapeutics Holding AG Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Relief Therapeutics Holding AG. The current atr is 0.08676538.

Relief Therapeutics Holding AG Daily Average True Range (ATR) ChartRelief Therapeutics Holding AG Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Relief Therapeutics Holding AG. The current obv is -1,199,830.

Relief Therapeutics Holding AG Daily On-Balance Volume (OBV) ChartRelief Therapeutics Holding AG Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Relief Therapeutics Holding AG. The current mfi is 41.70.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Relief Therapeutics Holding AG Daily Money Flow Index (MFI) ChartRelief Therapeutics Holding AG Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Relief Therapeutics Holding AG.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Relief Therapeutics Holding AG Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Relief Therapeutics Holding AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.022
Ma 20Greater thanMa 501.298
Ma 50Greater thanMa 1001.425
Ma 100Greater thanMa 2001.587
OpenGreater thanClose1.250
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Relief Therapeutics Holding AG with someone you think should read this too:
  • Are you bullish or bearish on Relief Therapeutics Holding AG? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Relief Therapeutics Holding AG? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Relief Therapeutics Holding AG

I send you an email if I find something interesting about Relief Therapeutics Holding AG.


Comments

How you think about this?

Leave a comment

Stay informed about Relief Therapeutics Holding AG.

Receive notifications about Relief Therapeutics Holding AG in your mailbox!